Biocartis introduces new Idylla assay for gene fusion testing
Molecular diagnostics firm Biocartis has launched Idylla GeneFusion Assay as a rapid lab workflow solution for gene fusion testing.
Jangoulun Singsit
Latest articles
All Articles
FDA grants marketing authorisation to BioFire’s SARS-CoV-2 diagnostic test
The US Food and Drug Administration (FDA) has granted marketing authorisation to BioFire Diagnostics’ SARS-CoV-2 test.
GenScript and G42 Healthcare partner to explore solutions for Covid-19
GenScript Biotech’s subsidiary GenScript Biotech Singapore has signed an agreement with UAE’s G42 Healthcare for exploring new solutions to…
EUROIMMUN introduces automated microscope for advanced diagnostics
PerkinElmer’s subsidiary EUROIMMUN has introduced the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope with EUROLabOffice 4.0 (ELO 4.0) software…
University of Rhode Island develops new saliva-based Covid-19 test
Researchers at the University of Rhode Island (URI) in the US have developed a saliva-based test to detect the…
MicroPort sees increased adoption of Kinematic Alignment for knee system
MicroPort Orthopedics has announced that it witnessed increased adoption of its Kinematic Alignment (KA) approach for the Evolution Medial-Pivot…
Roche launches new SARS-CoV-2 test to detect virus mutations
Roche has launched new SARS-CoV-2 research use only laboratory test to help monitor emerging mutations of coronavirus.
FDA clears Olympus’ NBI to characterise colorectal polyps potential
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Olympus’ Narrow Band Imaging (NBI) to assess…
Fujifilm Europe unveils antigen test kit for SARS-CoV-2 detection
Fujifilm Europe has launched its rapid antigen test kit for the detection of SARS-CoV-2 infection, following the receipt of…